Lui Temelkovski at the Health Committee

I call the meeting to order.

Pursuant to Standing Order 108(2), we are continuing our study on post-market surveillance of pharmaceutical products.

Today we have with us Alan Cassels, a pharmaceutical policy researcher, School of Health Information Sciences, University of Victoria; Mary Wiktorowicz, chair and associate professor, School of Health Policy and Management, York University; and have Robyn Tamblyn, science director, McGill Clinical and Health Informatics, Department of Medicine, McGill University.

We will start with ten-minute opening remarks from each presenter, and then we will go into our question and answer session.

I thank you for coming here and bringing all of your good information. We will start with Mr. Cassels.